MorphoSys AG
Patents, Design & Utilities
Last updated:
List of all MorphoSys AG patents 55 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS Filling date: 7 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: ANTI-CD19 THERAPY IN PATIENTS HAVING A LIMITED NUMBER OF NK CELLS Filling date: 7 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: ANTI-CD19 ANTIBODY FORMULATIONS Filling date: 7 Sep 2025 Issue date: 7 Jul 2022 |
Grant | Utility: Peptide libraries Filling date: 7 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Anti-CD19 antibody formulations Filling date: 7 Sep 2025 Issue date: 7 Jun 2022 |
Application | Utility: ANTI-CD38 ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF AUTOANTIBODY-MEDIATED AUTOIMMUNE DISEASE Filling date: 7 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: FAB Molecules with a Rodent Hinge Region and a Non-Rodent CH1 Region Filling date: 7 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: ANTIBODIES TARGETING C5AR Filling date: 7 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: ANTIBODY FORMULATIONS Filling date: 7 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: COMBINATIONS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 24 Mar 2022 |
Grant | Utility: Fab molecules with a rodent hinge region and a non-rodent CH1 region Filling date: 7 Sep 2025 Issue date: 22 Feb 2022 |
Application | Utility: PHARMACEUTICAL COMBINATIONS FOR TREATING TUMOR COMPRISING ANTI-CD19 ANTIBODY AND NATURAL KILLER CELL Filling date: 7 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: MULTISPECIFIC ANTIGEN-BINDING MOLECULES Filling date: 7 Sep 2025 Issue date: 10 Feb 2022 |
Grant | Utility: Combinations and uses thereof Filling date: 7 Sep 2025 Issue date: 18 Jan 2022 |
Application | Utility: ANTI-GM-CSF ANTIBODIES Filling date: 7 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: CANINE ANTIBODY LIBRARIES Filling date: 7 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: GENERATION AND PROFILING OF FULLY HUMAN HuCAL GOLD-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38 Filling date: 7 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: TREATMENT PARADIGM FOR AN ANTI-CD19 ANTIBODY AND VENETOCLAX COMBINATION TREATMENT Filling date: 7 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: High Concentration Liquid Antibody Formulations Filling date: 7 Sep 2025 Issue date: 19 Aug 2021 |
Grant | Utility: Polypeptide library Filling date: 7 Sep 2025 Issue date: 10 Aug 2021 |
Application | Utility: ANTIBODIES TARGETING GLYCOPROTEIN VI Filling date: 7 Sep 2025 Issue date: 15 Jul 2021 |
Grant | Utility: Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38 Filling date: 7 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Nucleic acid encoding anti-GM-CSF antibodies Filling date: 7 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Canine antibody libraries Filling date: 7 Sep 2025 Issue date: 25 May 2021 |
Application | Utility: TREATMENT FOR RHEUMATOID ARTHRITIS Filling date: 7 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND GAMMA DELTA T-CELLS Filling date: 7 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: ANTI-CD19 THERAPY IN COMBINATION WITH LENALIDOMIDE FOR THE TREATMENT OF LEUKEMIA OR LYMPHOMA Filling date: 7 Sep 2025 Issue date: 6 May 2021 |
Grant | Utility: Rodent combinatorial antibody libraries Filling date: 7 Sep 2025 Issue date: 16 Feb 2021 |
Grant | Utility: Treatment for rheumatoid arthritis Filling date: 7 Sep 2025 Issue date: 9 Feb 2021 |
Application | Utility: PEPTIDE LIBRARIES Filling date: 7 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: HUMANIZED ANTIBODIES FOR CD3 Filling date: 7 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: COMBINATIONS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: COMBINATIONS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 12 Nov 2020 |
Grant | Utility: Peptide libraries Filling date: 7 Sep 2025 Issue date: 3 Nov 2020 |
Application | Utility: COMPLEX-SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS AND ITS USE Filling date: 7 Sep 2025 Issue date: 29 Oct 2020 |
Grant | Utility: Antagonists of IL17C for the treatment of inflammatory disorders Filling date: 7 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Complex-specific antibodies and antibody fragments and its use Filling date: 7 Sep 2025 Issue date: 15 Sep 2020 |
Application | Utility: POLYPEPTIDE LIBRARY Filling date: 7 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: CANINE ANTIBODY LIBRARIES Filling date: 7 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: ANTIBODIES FOR IL-17C Filling date: 7 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 2 Jul 2020 |
Grant | Utility: Polypeptide library Filling date: 7 Sep 2025 Issue date: 19 May 2020 |
Grant | Utility: Collection and methods for its use Filling date: 7 Sep 2025 Issue date: 12 May 2020 |
Grant | Utility: Antibodies for IL-17C Filling date: 7 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Utility: Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor and uses thereof Filling date: 7 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Antagonists of IL-17C for the treatment and/or prevention of atopic dermatitis Filling date: 7 Sep 2025 Issue date: 31 Mar 2020 |
Application | Utility: TREATMENT FOR MULTIPLE MYELOMA (MM) Filling date: 7 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: ANTI-GM-CSF ANTIBODIES Filling date: 7 Sep 2025 Issue date: 23 Jan 2020 |
Grant | Utility: Treatment for multiple myeloma (MM) Filling date: 7 Sep 2025 Issue date: 14 Jan 2020 |
Application | Utility: ANTIBODIES FOR IL-17C Filling date: 7 Sep 2025 Issue date: 9 Jan 2020 |
Showing 1 to 50 of 55 patents.